DK2125794T3 - Imidazolidinonylaminopyrimidin-forbindelser til behandling af cancer - Google Patents

Imidazolidinonylaminopyrimidin-forbindelser til behandling af cancer

Info

Publication number
DK2125794T3
DK2125794T3 DK07855060.5T DK07855060T DK2125794T3 DK 2125794 T3 DK2125794 T3 DK 2125794T3 DK 07855060 T DK07855060 T DK 07855060T DK 2125794 T3 DK2125794 T3 DK 2125794T3
Authority
DK
Denmark
Prior art keywords
aminomethyl
hydrogen
halo
alkyl
cancer
Prior art date
Application number
DK07855060.5T
Other languages
English (en)
Inventor
Harold Burns Brooks
Hong-Yu Li
Joyce Z Crich
James Robert Henry
Jason Scott Sawyer
Yan Wang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK2125794T3 publication Critical patent/DK2125794T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
DK07855060.5T 2006-12-21 2007-12-11 Imidazolidinonylaminopyrimidin-forbindelser til behandling af cancer DK2125794T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87132206P 2006-12-21 2006-12-21
PCT/US2007/087046 WO2008076705A1 (en) 2006-12-21 2007-12-11 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer

Publications (1)

Publication Number Publication Date
DK2125794T3 true DK2125794T3 (da) 2011-01-24

Family

ID=39185681

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07855060.5T DK2125794T3 (da) 2006-12-21 2007-12-11 Imidazolidinonylaminopyrimidin-forbindelser til behandling af cancer

Country Status (21)

Country Link
US (1) US8063212B2 (da)
EP (1) EP2125794B1 (da)
JP (1) JP2010513553A (da)
KR (1) KR101080594B1 (da)
CN (1) CN101568539B (da)
AT (1) ATE485291T1 (da)
AU (1) AU2007334040B2 (da)
BR (1) BRPI0720607A2 (da)
CA (1) CA2673564A1 (da)
CY (1) CY1110950T1 (da)
DE (1) DE602007010041D1 (da)
DK (1) DK2125794T3 (da)
EA (1) EA016178B1 (da)
ES (1) ES2351371T3 (da)
HR (1) HRP20100641T1 (da)
MX (1) MX2009006635A (da)
PL (1) PL2125794T3 (da)
PT (1) PT2125794E (da)
RS (1) RS51526B (da)
SI (1) SI2125794T1 (da)
WO (1) WO2008076705A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2671738A1 (en) 2006-12-21 2008-06-26 Eli Lilly And Company Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
BRPI0811433A2 (pt) * 2007-05-16 2016-03-22 Lilly Co Eli compostos do tipo triazolil aminopirimidina
BR112014030954A2 (pt) 2012-06-14 2017-06-27 Daiichi Sankyo Co Ltd composto , composição farmacêutica , ativador de lecitina-colesterol aciltransferase , agente antiaterosclerótico , agente profilático ou terapêutico para aterosclerose , agente para diminuir a concentração de colesterol ldl no sangue e para elevar a concentração de colesterol hdl no sangue , uso de um composto , e , métodos para ativar lecitina-colesterol aciltransferase , e para o tratamento ou profilaxia de uma doença.
EP2929883A1 (en) 2014-04-08 2015-10-14 Institut Pasteur Pyrazole derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors
KR20230142927A (ko) 2022-04-04 2023-10-11 경희대학교 산학협력단 나프탈렌-2-일알킬기가 치환된 이미다졸리움 유도체 및 이를 유효성분으로 포함하는 암 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
WO2004063192A1 (en) * 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
CA2590939C (en) * 2004-12-17 2011-10-18 Amgen Inc. Aminopyrimidine compounds and methods of use
TW200800201A (en) * 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
US8008481B2 (en) 2006-03-31 2011-08-30 Ericsson Anna M Indazole compounds
CA2671738A1 (en) 2006-12-21 2008-06-26 Eli Lilly And Company Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
KR101131254B1 (ko) 2007-05-16 2012-04-24 일라이 릴리 앤드 캄파니 트리아졸릴 아미노피리미딘 화합물
BRPI0811433A2 (pt) 2007-05-16 2016-03-22 Lilly Co Eli compostos do tipo triazolil aminopirimidina

Also Published As

Publication number Publication date
EP2125794B1 (en) 2010-10-20
AU2007334040B2 (en) 2012-02-16
CA2673564A1 (en) 2008-06-26
WO2008076705A1 (en) 2008-06-26
HRP20100641T1 (hr) 2010-12-31
CN101568539A (zh) 2009-10-28
SI2125794T1 (sl) 2011-02-28
RS51526B (en) 2011-06-30
EA200970616A1 (ru) 2009-10-30
KR20090086111A (ko) 2009-08-10
US8063212B2 (en) 2011-11-22
EA016178B1 (ru) 2012-02-28
JP2010513553A (ja) 2010-04-30
PT2125794E (pt) 2011-01-10
MX2009006635A (es) 2009-06-30
PL2125794T3 (pl) 2011-04-29
KR101080594B1 (ko) 2011-11-04
US20100081641A1 (en) 2010-04-01
BRPI0720607A2 (pt) 2014-04-08
CN101568539B (zh) 2012-04-25
AU2007334040A1 (en) 2008-06-26
ATE485291T1 (de) 2010-11-15
CY1110950T1 (el) 2015-06-10
EP2125794A1 (en) 2009-12-02
ES2351371T3 (es) 2011-02-03
DE602007010041D1 (de) 2010-12-02

Similar Documents

Publication Publication Date Title
TW200621786A (en) Condensed pyrazole derivatives, their preparation and application in therapeutics
TW200642683A (en) Heterocyclic compound
WO2005080384A3 (en) Benzimidazole derivative and use as aii receptor antagonist
SI2091948T1 (sl) Novi inhibitorji glutaminil ciklaze
DE602005016297D1 (de) Antithrombotische diamide
EA200501585A1 (ru) Производные азетидинкарбоксамида и их применение при лечении нарушений, опосредованных св1 рецепторами
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
EA200870358A1 (ru) 2-(циклический амино) пиримидоновые производные в качестве ингибиторов tpk1
EA201000050A1 (ru) Замещенные бициклолактамные соединения
ATE437872T1 (de) Proteinkinaseinhibitoren
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
BR112014003237A2 (pt) compostos de indazol, composições e métodos de uso
NO20074177L (no) Substituerte triazolderivater som oksytocinantagonister
MX2012000441A (es) Derivados de 1,2,4-tiazolidin-3-ona y uso en el tratamiento del cancer.
MY151295A (en) Pyrimidyl indoline compound
DK1696905T3 (da) Substituerede 2-aminotetraliner til forebyggende behandling af Morbus Parkinson
MA38315B1 (fr) Composés tétracycliques substitués par un hétérocycle et procédés pour les utiliser pour le traitement de maladies virales
TW200716547A (en) Piperidin-4-yl-amide derivatives
MX2010001566A (es) Derivado de aminopirazolamida.
CY1110950T1 (el) Ενωσεις ιμιδαζολιδινονυλ αμινοπυριμιδινης για τη θεραπευτικη αντιμετωπιση του καρκινου
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
DE602007001463D1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate
MY158069A (en) Tricyclic compound and pharmaceutical use thereof
BRPI0918966B8 (pt) composto inibidor de protease, composição farmacêutica compreendendo dito composto e uso terapêutico do mesmo